相似文献
1
A 24-year-old woman with rapidly progressing vision loss.
Digit J Ophthalmol. 2017 Jan 15;23(1):36-39. doi: 10.5693/djo.03.2016.10.001. eCollection 2017.
2
Idiopathic intracranial hypertension: is papilloedema inevitable?
Arch Dis Child. 2002 Sep;87(3):223-4. doi: 10.1136/adc.87.3.223.
3
Headaches, idiopathic intracranial hypertension, and pseudopapilledema.
Am J Med Sci. 1998 Dec;316(6):408-10. doi: 10.1097/00000441-199812000-00011.
4
Presumed idiopathic intracranial hypertension: A case report and literature review.
Niger J Med. 2011 Apr-Jun;20(2):289-91.
5
[Idiopathic intracranial hypertension is a serious condition in rapid growth].
Ugeskr Laeger. 2012 Jun 18;174(25):1737-40.
6
[Rapidly progressing visual loss in idiopathic intracranial hypertension].
Ugeskr Laeger. 2009 Jan 26;171(5):316-7.
7
Intracranial hypertension and visual loss following COVID-19: A case report.
Indian J Ophthalmol. 2021 Jun;69(6):1625-1627. doi: 10.4103/ijo.IJO_342_21.
8
Bilateral peripapillary subretinal neovessel membrane associated with chronic papilledema: report of two cases.
Klin Monbl Augenheilkd. 2005 Mar;222(3):275-8. doi: 10.1055/s-2005-857981.
9
Recovery of vision in fulminant idiopathic intracranial hypertension.
CMAJ. 2019 Jun 10;191(23):E639. doi: 10.1503/cmaj.190024.
10
A sonographic sign of papilledema.
J Emerg Med. 2013 Nov;45(5):708-9. doi: 10.1016/j.jemermed.2013.04.039. Epub 2013 Aug 29.
引用本文的文献
1
Non-arteritic anterior ischemic optic neuropathy secondary to idiopathic intracranial hypertension.
Am J Ophthalmol Case Rep. 2024 Apr 16;34:102057. doi: 10.1016/j.ajoc.2024.102057. eCollection 2024 Jun.
本文引用的文献
1
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.
Neurology. 2013 Sep 24;81(13):1159-65. doi: 10.1212/WNL.0b013e3182a55f17. Epub 2013 Aug 21.
2
Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy?
J Neuroophthalmol. 2013 Jun;33(2):183-8. doi: 10.1097/WNO.0b013e318292d06f.
3
Papilledema: are we any nearer to a consensus on pathogenesis and treatment?
Curr Neurol Neurosci Rep. 2012 Jun;12(3):334-9. doi: 10.1007/s11910-012-0257-8.
4
Stenting of the transverse sinuses in idiopathic intracranial hypertension.
J Neuroophthalmol. 2011 Dec;31(4):374-80. doi: 10.1097/WNO.0b013e318237eb73.
5
Surgical interventions for idiopathic intracranial hypertension.
Curr Opin Ophthalmol. 2009 Nov;20(6):451-5. doi: 10.1097/ICU.0b013e3283313c1c.
6
Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension).
Cephalalgia. 2008 Dec;28(12):1361-73. doi: 10.1111/j.1468-2982.2008.01778.x.
7
Fulminant idiopathic intracranial hypertension.
Neurology. 2007 Jan 16;68(3):229-32. doi: 10.1212/01.wnl.0000251312.19452.ec.
8
Non-operative management of benign intracranial hypertension presenting with complete visual loss and deafness.
Pediatr Neurosurg. 2006;42(1):62-4. doi: 10.1159/000089513.
9
Interventions for idiopathic intracranial hypertension.
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003434. doi: 10.1002/14651858.CD003434.pub2.
10
Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002.
Neurosurgery. 2005 Jul;57(1):97-108; discussion 97-108. doi: 10.1227/01.neu.0000163094.23923.e5.
Zotero 插件